Andrew Campbell
- Epidemiology top 5%
- Hepatology top 0.5%
- Infectious Diseases top 5%
- Rheumatology top 5%
- Hematology top 10%
- Co-authors
- Betsy C. HeroldChristine A. CollinsBarry BernsteinThomas PodsadeckiSandra LovellFred PoordadKris V. KowdleyRoger Trinh
- Topics
- Hepatitis C virus research (14 papers)Hepatitis B Virus Studies (9 papers)HIV/AIDS drug development and treatment (7 papers)
- Partner nations
- United StatesUnited KingdomChile
In The Last Decade
Andrew Campbell
32 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Epidemiology 967
- Hepatology 953
- Infectious Diseases 388
- Rheumatology 170
- Hematology 78
Countries citing papers authored by Andrew Campbell
This map shows the geographic impact of Andrew Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Campbell more than expected).
Fields of papers citing papers by Andrew Campbell
This network shows the impact of papers produced by Andrew Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Campbell. The network helps show where Andrew Campbell may publish in the future.
Co-authorship network of co-authors of Andrew Campbell
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Campbell. A scholar is included among the top collaborators of Andrew Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Campbell. Andrew Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 30 | |
| 4 | 12 | |
| 5 | 20 | |
| 6 | 37 | |
| 7 | ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosisbreakdown → | 646 |
| 8 | 1 | |
| 9 | 20 | |
| 10 | 45 | |
| 11 | 58 | |
| 12 | RSV HOSPITALIZATION RATES IN PRETERM CHILDREN IN THE SEASON FOLLOWING PALIVIZUMAB PROPHYLAXIS COMPARED TO CHILDREN WITHOUT PALIVIZUMAB PROPHYLAXIS | 3 |
| 13 | 2 | |
| 14 | 60 | |
| 15 | 41 | |
| 16 | 9 | |
| 17 | 33 | |
| 18 | 1 | |
| 19 | 2 | |
| 20 | 103 |
About Andrew Campbell
Andrew Campbell is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 34 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (9 papers) and HIV/AIDS drug development and treatment (7 papers). The work is most often cited by research in Hepatology (953 citations), Epidemiology (967 citations) and Infectious Diseases (388 citations). Andrew Campbell has collaborated with scholars based in United States, United Kingdom and Chile. Frequent co-authors include Betsy C. Herold, Christine A. Collins, Barry Bernstein, Thomas Podsadecki, Sandra Lovell, Fred Poordad, Kris V. Kowdley, Roger Trinh, Mitchell L. Shiffman and Christophe Hézode. Their work appears in journals such as New England Journal of Medicine, Nature Reviews Drug Discovery and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.